This cluster randomized clinical trial investigates the effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician on health-related quality of life and other patient-relevant outcomes in home-dwelling older patients receiving polypharmacy.
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
Read the current issue. Keep up to date with the latest research, clinical reviews, and opinions.
In the first publication on continuous intracranial pressure (ICP) monitoring in patients with traumatic brain injury (TBI) in 1965, Lundberg et al1 described periodic increases…
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This Clinical Insight reviews the lifestyle factors important for patients receiving glucagon-like peptide-1 and dual receptor agonists to manage weight.
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still matter, doctors say.
This cohort study examines rates of positive tests, hospitalizations, and deaths for COVID-19 and influenza across the influenza seasons of 2022 to 2023, 2023 to…
This prognostic study describes the development and validation of survival models using electronic health record data to predict the time to progression to proliferative diabetic…
